Form D — Jasper Therapeutics, Inc.
0001213900-26-085315 · filed Aug 5, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $131,999,611
- Total sold
- $131,999,611
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Jasper Therapeutics, Inc.
- CIK
- 1788028
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2200 BRIDGE PKWY
REDWOOD CITY, CA 94065 - Phone
- 650-549-1400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Herb Cross · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Jeet Mahal · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Patrick Crutcher · DirectorRedwood City, CA Find on LinkedIn ↗
-
Thomas Wiggans · DirectorRedwood City, CA Find on LinkedIn ↗
-
Judith Shizuru · DirectorRedwood City, CA Find on LinkedIn ↗
-
Svetlana Lucas · DirectorRedwood City, CA Find on LinkedIn ↗
-
Kurt von Emster · DirectorRedwood City, CA Find on LinkedIn ↗
-
Wenru Song · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Gregory F. Keenan · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Matthew E. Ros · DirectorRedwood City, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗